ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX) is a Healthcare stock tracked by StreetAlpha. IBRX reports earnings on Tue, Nov 3, 2026. Over the past 90 days StreetAlpha recorded 1 whale options trade in IBRX, 100% of them bullish and 0% bearish. In the past 30 days there were 2 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 21 | BTIG | Reiterated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IBRX is in one of them and how their past IBRX trades turned out.
IBRX News Tone and Price
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered IBRX in an article yet. Here's the latest on the wider market.
IBRX Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Lisa McClainR · MI | Buy | $1K – $15K | Sep 30, 2026 | Oct 13, 2026 | 13 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Sep 28, 2026 | Oct 13, 2026 | 15 d |
| Dan GoldmanD · NY | Sell | $1K – $15K | Mar 6, 2023 | Apr 17, 2023 | 42 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.